Latest Financial Performance News

Control Bionics Limited reported a 14.8% revenue increase to $6.14 million for FY2025 but also a 3.3% rise in net loss to $6.11 million, while pursuing a $2 million rights issue and expanding its investment portfolio.

Orion Equities reported a $1.33 million net profit for FY25, down 56% from the prior year, impacted by unrealised losses on key investments and a significant tax benefit reversal. The company’s portfolio remains anchored by stakes in Bentley Capital and Strike Resources.

Gumtree Australia Markets Limited has completed the sale of its Capital Markets business, reporting a 6% revenue decline but a notable rise in EBITDA from its core Classifieds segment. The company is now focused on expanding its transactional offerings and strategic partnerships.

Pentanet has achieved its first full-year positive EBITDA of $1.4 million in FY25, driven by strong growth in 5G subscribers and a profitable gaming segment. The company’s strategic focus on capital-efficient 5G expansion and gaming platform optimisation signals a new phase of growth.

RemSense Technologies posted a 107% revenue surge to $3.44 million in FY2025 alongside a 67% reduction in net loss, driven by operational efficiencies and strong client demand. The company achieved positive cash EBITDA and strengthened its global footprint with Tier 1 clients.

Gold Road Resources reports a robust half-year profit surge driven by higher gold prices and sales, while advancing a proposed acquisition by Gold Fields with a shareholder vote set for September.

WhiteHawk Limited reports an 8.6% revenue increase and a 26% reduction in net loss for H1 2025, alongside new US government contracts and a $1.56 million capital raise.

Sayona Mining delivered record lithium concentrate production and sales in FY25, driving revenue to $223 million despite a 16% drop in selling prices. The company also recorded a significant $271 million impairment on its North American Lithium assets amid weaker market conditions.

Noxopharm Limited reported a 36.5% increase in its annual loss to $4.88 million as it progressed preparations for its SOF-SKN™ clinical trial and secured $2.6 million through convertible notes. The biotech continues to invest heavily in its inflammation and oncology drug pipeline while managing liquidity and strategic partnerships.

Sayona Mining reported an 11% revenue increase to $223 million but posted a $294 million loss driven by a significant impairment of its North American Lithium assets.

Austal Limited has reported a remarkable 24% revenue increase and a 503% surge in net profit for FY2025, yet has chosen not to declare any dividends for the year.

Rent.com.au Limited reported a $3.69 million net loss for FY25 amid modest revenue growth, while securing significant funding to scale its RentBond® product and reshaping its leadership team.